Q3 2014

Filed Nov 13, 2014 · 10-Q · 44 days after period end · 0001213900-14-008012

Q3 2014 · 10-Q

Revenue

$41.50K

−25.5% vs Q3 2013

Net Income

-$1.12M

N/M vs Q3 2013

EPS Diluted

$0.00

— vs Q3 2013

Gross Profit$7,189−50.5%

Operating Income

Same quarter

Metric	Q3 2014	Q3 2013	Q3 2012	Q3 2011
Revenue	$41.50K	$55.69K	-$9.93K	$13.20K
Net Income	-$1.12M	-$277.18K	-$487.33K	-$346.04K
EPS Diluted	$0.00	$0.00	$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Bioxytran, Inc · CIK 1445815 · Engraved from SEC EDGAR